Maduck Sean bought CORT
November 2, 2026 · Form 4 insider transaction
Maduck Sean bought 11,841 shares of Corcept Therapeutics Incorporated at $8.27 per share, a transaction worth $97.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
Includes 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 150 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.; Reflects a transfer of shares of Common Stock between direct and indirect accounts over which the Reporting Person has beneficial ownership. The transfer resulted only in a change in the form of the Reporting Person's beneficial ownership and is exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended.